Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843554 · ClinicalTrials.gov registry record · NA
Commensal Oral Microbiota in Head and Neck Cancer
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03843554: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT03843554 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03843554, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The ARMOR Trial will test the efficacy of an oral care protocol to treat oral mucositis (OM) in patients receiving radiation (RT) or chemoradiation (chemoRT) for head and neck cancer. Participants will attend a screening/baseline visit, weekly intervention visits while they are undergoing RT or chemoRT, and a visit 3 months after completing RT or chemoRT. At intervention visits, samples will be collected (such as saliva, oral swabs) and participants will receive their assigned study intervention, either Oral Mucosal Deterging and Dental Prophylaxis protocol (OMDP), which includes a dental cleaning and treatment to the oral mucosa, or a Standard of Care Oral Hygiene, which includes teeth brushing and no treatment to the oral mucosa.
Interventions
- OTHER Standard of Care Oral Hygiene
- PROCEDURE Oral mucosal deterging and dental prophylaxis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2022-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03843554
The ClinicalTrials.gov registry entry for NCT03843554 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care Oral Hygiene is the first listed.
NCT03843554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03843554 about?
NCT03843554 is a clinical study titled "Commensal Oral Microbiota in Head and Neck Cancer". The ARMOR Trial will test the efficacy of an oral care protocol to treat oral mucositis (OM) in patients receiving radiation (RT) or chemoradiation (chemoRT) for head and neck cancer. Participants will attend a screening/baseline visit, weekly intervention visits while they are undergoing RT or chem...
What is the current status of trial NCT03843554?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2019-09-23. Estimated completion is 2022-08-03.
What interventions are being tested in trial NCT03843554?
The interventions under investigation include: Standard of Care Oral Hygiene (OTHER), Oral mucosal deterging and dental prophylaxis (PROCEDURE).
Who is sponsoring clinical trial NCT03843554?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.